This study aimed to assess and compare the effects of urapidil and clo
nidine on right ventricular volumes and function in 20 physical status
ASA III patients, with a bordeline untreated essential hypertension a
nd with or without chronic coronary artery disease. The patients were
randomly assigned to two equal groups to receive either urapidil (0.4
mg . kg-1) or clonidine (2.5 mug . kg-1). Neither patient had congesti
ve heart failure, valvular heart disease, previous myocardial infarcti
on, nor was any being treated with beta-blocking agents or with amioda
rone. Usual anti-anginal medication (nifedipine and isosorbide) was ma
intained up to the time of the procedure. Monitoring was obtained from
ECG, Swan-Ganz catheter fitted out with a fast response-thermistor, a
nd radial artery cannula. Blood samples were withdrawn for plasma atri
al natriuretic factor determination. Thirty minutes after catheter ins
ertion, baseline data were collected in supine and 45-degrees head-up
tilt positions. Following urapidil or clonidine i.v. injection, three
series of measurements (3, 8 and 13 min) were made in supine and tilt
positions according to a randomized sequence. The two groups were simi
lar with regard to age, weight, height, coronary artery disease and tr
eatment. Urapidil and clonidine elicited a similar decrease in mean ar
terial pressure of 14 % in supine position and 20 % in head-up tilt po
sition, combined with an exclusive decrease in systolic index i.e. not
associated with a change in peripheral vascular resistances. Despite
the decrease in arterial pressure, heart rate remained unchanged. Righ
t ventricular ejection fraction was maintained after both urapidil and
clonidine, however end-diastolic and end-systolic volumes decreased,
with no modification by tilting. Atrial natriuretic factor decreased a
fter - both urapidil and clonidine injection. This study substantiates
the decrease of venous return elicited by the peripheral venodilation
and blood pooling following the i.v. injection of urapidil,